with BTF ICP monitoring guidelines is associated with improved outcomes.
After obtaining approval from the institutional review board, we conducted a prospective observational study of trauma patients with severe blunt TBI (Glasgow Coma Scale [GCS] score 8 and head Abbreviated Injury Scale [AIS] score 3) who met the BTF inclusion criteria for ICP monitoring and were admitted to the surgical ICU at Los Angeles County and University of Southern California Medical Center between January 01, 2010, and December 30, 2011. The decision to place an ICP monitoring device was at the neurosurgeon's discretion. Exclusion criteria included the pediatric population (age < 18 years), patients who were moribund, and those who were not expected to improve prior to the decision of whether an ICP monitoring device would be placed. Placement of ICP monitoring devices occurred in all instances in the Demographic and clinical data collected included age, sex, blood pressure on admission, GCS score on admission, Injury Severity Score (ISS), AIS for each body region (head, chest, abdomen, and extremity), type of intracranial injury, ICP values in patients undergoing intervention, intracranial hemorrhage (ICH) treatment modalities, and neurosurgical documentation for omission of used, allowing the treating physicians to choose from a as to why an ICP monitoring device was not placed. In physician could write down the reason for not placing an ICP monitoring device. patients subjected to ICP monitoring and those not undergoing ICP monitoring. All subsequent analyses were peras higher than 20 mm Hg for more than 15 minutes based on the BTF guidelines.
Primary outcomes included compliance with BTF guidelines, overall in-hospital mortality, and mortality due to brain herniation. Secondary outcomes were ICU and hospital lengths of stay (LOSs).
Statistical Analysis -cally relevant cut points: age ( 55 years vs > 55 years), vs 1.3 vs 1.3), ISS ( 15, (16) (17) (18) (19) (20) (21) (22) (23) (24) 25) , AIS score ( 3 vs < 3), and heart rate on admission (> 120 bpm vs 120 bpm). The 2 groups were compared for differences in categorical variables using the Fisher exact or Pearson chi-square tests as appropriate. The Shapiro-Wilk Test for normality was deployed for continuous variables; normally distributed variables were compared using the Student t-test while nonnormally distributed variables were compared using the Mann-Whitney U-test.
To identify independent predictors of ICP monitoring, a forward stepwise logistic regression was deployed using variables at a p < 0.2 level after univariate analysis.
Subsequent univariate analyses for in-hospital mortality and mortality due to brain herniation were performed. Independent predictors of in-hospital mortality and mortality due to brain herniation were derived from forward stepwise regression models using variables from each univariate model that were different at p < 0.2. A variance 5 for each variable entered in the models was considered as evidence of multicolinearity.
To correct for the differences between the groups (ICP monitoring vs no ICP monitoring), logistic regression was performed using as independent variables the placement of the ICP monitoring device, adjusting for differences between the groups at p < 0.05. The regression calculated the predicted probability (propensity score) of being subjected to ICP monitoring using variables that independently predicted the placement of an ICP monitoring device. Propensity score matching is a technique that tries to estimate the effect of a treatment by accounting for the covariates that predict receiving the treatment. It was performed in an effort to reduce the bias due to confounding factors that might be involved in comparing outcomes among patients who received the treatment with outcomes of those who did not. The overall in-hospital mortality and mortality due to brain herniation were assessed for each study group using logistic regression to propensity score was also inserted in the regression as were derived from the logistic regression. An AOR < 1.00 the odds of developing the outcome, whereas an AOR > -ing the outcome. implies that the factor does not predict the outcome. The hospital and ICU LOSs and ventilator days were compared using an independent t-test or Mann-Whitney Utest and subsequently linear regressions adjusting for difmortality bias, the same tests were deployed after exclusion of deaths.
Values are reported as the mean SEM for continuous variables and as percentages for categorical variables. All analyses were performed using SPSS for Windows (version 12.0, SPSS, Inc.).
Overall, 216 patients who sustained a severe TBI met the BTF guidelines for ICP monitoring. The epidemiological and clinical characteristics of the study population are shown in Table 1 . Hypotension was present in 5.6% of Almost half of the patients (43.5%) had a GCS score of 3 on admission and 44.4% had a head AIS score of 5.
A total of 46.8% of patients who met the BTF criteria -lostomy EMDS II (Medtronic Corp.) was placed in 60 pa--tegra LifeSciences Corp.) was placed in 41 patients (41%).
of care. However, 58% of patients subjected to ventriculosdevice. The most common reason for not placing an ICP monitoring device was the treating physician's decision (Table 1) .
The independent predictors for ICP monitoring de--dergoing decompressive craniectomy or patients with an extremity AIS score 3 were more likely to be subjected --creased partial thromboplastin time (PTT) on admission -or those who were hypotensive on admission (AOR 0.13 -ly less likely to undergo ICP monitoring. We noted no difference in mortality for the ICP monitoring group when the 2 devices were compared (Table 3) .
For the patients subjected to ICP monitoring, the highest mean ICP noted in the study sample was 33.4 2.3 mm Hg ( undergoing ICP monitoring who experienced episodes of 73.4%, pentobarbital coma in 23.4%, hypertonic saline infusion in 62.5%, mannitol bolus in 54.7%, hyperventilation in 51.6%, decompressive craniectomy in 15.6%, hypothermia in 14.1%, and paralysis in 3.1% of cases.
Intracranial pressure monitoring was noted to be an independent predictor of overall in-hospital mortality hours, and presence of SDH on CT. Intracranial pressure monitoring was also found to be an independent predictor of mortality due to brain herniation with an AOR of adjusted p < 0.001), loss of basal cisterns on CT (AOR 24 hours, and presence of IPH. The R 2 and the area under overall mortality and 0.474 and 0.887 for mortality due to brain herniation, respectively (Table 4 ). -tion was 5%. The incidence of pneumonia, acute kidney injury, and deep venous thrombosis/pulmonary embolism respectively; all of these complications occurred in the ICP study group. No incidents of acute respiratory distress syndrome and/or septic shock were noted. higher in patients not subjected to ICP monitoring after adjusting for relevant confounders between the groups (age, presence of hypotension on admission, head AIS score of 5, extremity AIS score 3, presence of IPH or SAH on CT, PTT on admission, early nutrition, decompressive craniectomy/craniotomy in 4 hours, decompressive craniectomy/ craniotomy in 24 hours, and probability of receiving ICP -higher in patients not subjected to ICP monitoring (21.7%
mentioned above]). Early deaths (< 48 hours) were equally distributed among the study groups.
for the group subjected to ICP monitoring before and after exclusion of deaths (Table 5 ).
The BTF guidelines support ICP monitoring in all salvageable patients with severe TBI (GCS score of 3-8 after resuscitation) with an abnormal CT scan depicting ICH, brain edema, herniation, or compressed basal cisterns (Level II evidence). In addition, patients with a GCS variables (unilateral/bilateral posturing, patient age 40 years, and presence of hypotension) are also candidates for ICP monitoring (Level III evidence 1 ). In brain injuries that are likely to require aggressive ICP management, a ventriculostomy is placed, which can also provide CSF drainage. Patients not likely to require CSF drainage are -vice, allowing continuous ICP monitoring.
The BTF guidelines are based on retrospective and limited prospective observational data; thus, the ICP compliance varies widely in neurocritical care, and the out- The BTF provides guidelines for physicians with regard to the type of patients who should receive ICP monitoring. It is worth noting, however, that these guidelines do not constitute a universal protocol and thus treating physicians commonly use their own experience and judgment to decide which patient will be subjected to ICP monitoring. Previous surveys of ICP monitoring in Europe and North 75% of patients with severe head injury in institutions providing neurocritical care.
Cremer et al. 4 performed a retrospective cohort study with prospective follow-up ( 12 months) in 2 trauma centers providing supportive therapy only compared with ICP/CPP-targeted management in the severe head injury population. The ICP/CPP-guided therapy did not improve in-hospital survival, and the follow-up Glasgow Outcome Scale score was similar in both study groups. At the center relying on ICP/CPP-targeted therapy, the prevalence of ICP monitoring was 67%. 4 tional Trauma Data Bank (NTDB) analysis and noted that ICP monitoring was applied in 43% of patients who met BTF criteria. 20 Likewise, we observed the prevalence of ICP monitoring in patients meeting BTF guideline criteria at 46.8%. In our prospective study we documented reasons for omission of ICP monitoring, which included neurosurgeon's discretion, decompressive craniotomy/ craniectomy precluding the need for an ICP device, and expectation of rapid neurological recovery. The independent predictors of ICP monitoring included SAH, early decompressive craniectomy, and severe extremity injury with AORs of 2.07, 3.85, and 3.01, respectively (Table 2) . Patients with increasing age, those experiencing coagulopathy, those with an elevated GCS score, or those pre- senting with hypotension on admission were less likely and 0.13, respectively). The univariate analysis comparing the patients who received ICP monitoring with those who did not revealed some differences in their basic characteristics, which, however, did not impact outcomes.
more likely not to receive an ICP monitoring device, the mean SBP did not differ between the groups (142 3 mm Hg vs 137 severity indices were not statistically different between the groups. Likewise, the severity of head injury based on head AIS and GCS score was equally distributed between -cidence of SAH and IPH. Finally, patients with admission coagulopathy were less likely to undergo ICP monitoring placement, not because of the severity of injury but to avoid potential bleeding due to the intervention. The main reason for not receiving an ICP monitoring device was at the discretion of the neurosurgical attending. Patients who were moribund or were assessed to have poor outcome on admission were excluded from the study per study design. In addition, a small percentage of patients who did not receive ICP monitoring were expected by the neurosurgeon to improve rapidly. That contrasts with the idea that ICP monitoring was not used in sicker patients -versally applied and each patient is treated based on phyplaced with no difference in overall mortality and mortality due to brain herniation when compared with ventriculostomy (Table 3) .
We performed a regression analysis to elucidate independent predictors for both overall and head injury-related independent predictors for overall in-hospital mor tality including devastating head injury (head AIS score of 5) and subdural hematoma (SDH) with AORs for poor outthat patients subjected to ICP monitoring experienced a adjustment for most clinically relevant confounders includprevious examinations have observed survival advantage in ICP-targeted therapy, but with less marked survival effect. 3, 5, 15, 16 However, a recent NTDB-based investigation by patients subjected to ICP monitoring. 20 These authors interpreted the BTF guidelines to be inadequate to identify these investigators suggested that the interventions in patients subjected to ICP monitoring may be associated with worsened outcomes. Such interventions include ICP moniof vasoactive medication, osmotic diuresis with mannitol, -lytics. We documented all of the above interventions in our study group subjected to ICP monitoring; nevertheless, despite all these potentially harmful interventions, these paWe noted extended ICU and hospital LOSs when ICP monitoring was instituted before and after exclusion of patients subjected to the intervention.
Our study has multiple limitations including the lack functional impairment measures. First, we attempted to regression models adjusting for an extensive number of clinically relevant confounders introducing propensity score into our analysis. Second, the patients were selected for all interventions at the discretion of the attending neurosurgeon without any strict protocol. Finally, it is likely that some of those patients in the group not receiving ICP monitoring were being treated differently-and perhaps less intensively-than those in the ICP monitoring group. Nevertheless, our data were collected prospectively and 
